Silab's natural anti-aging active, Senevisium, was awarded 1st prize at the C&T Allē Awards in the Actives/Anti-aging category at the Red Carpet Awards Gala on March 6, 2024 in Los Angeles, in conjunction with the Beauty Accelerate conference, less than a year after winning 1st prize at the ICIC Award and 1st prize at the Ringier Award in Asia.
For the development of this longevity concentrate from Ginkgo biloba (a supercentenarian tree with remarkable longevity), Silab has deciphered the phenomenon of immunoevasion, a strategy put in place by certain senescent fibroblasts to avoid being eliminated by the immune system. This natural elimination is nevertheless beneficial, since persistent senescent fibroblasts have deleterious effects on nearby cells.
Silab's research teams have developed some original modelling studies in vitro and in vivo which, according to the company, highlighted the accentuation of this immuno-evasion mechanism on a skin-wide scale after the age of 60. This mechanism leads to profound changes: wrinkles, dull complexion, loss of elasticity and age spots. Silab indicates that, through its targeted action, Senevisium is capable of counteracting the immunoevasion of senescent fibroblasts, enabling them to be eliminated by the immune system.
"We are delighted that the high scientific level of this active ingredient has been recognized by the cosmetics industry. Senevisium is in fact an innovative cosmetic solution, the fruit of a cutting-edge research program which has enabled us, for the first time, to highlight the consequences of the immunoevasion of senescent fibroblasts during skin ageing".says Brigitte Closs-Gonthier, Chairman of the Board and General Manager in charge of R&D, Quality and Communications at Silab.
Photo taken from the Silab website.
